ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7

We investigated ChAdOx1 nCoV-19 (AZD1222) vaccine efficacy against SARS-CoV-2 variants of concern (VOCs) B.1.1.7 and B.1.351 in Syrian hamsters. We previously showed protection against SARS-CoV-2 disease and pneumonia in hamsters vaccinated with a single dose of ChAdOx1 nCoV-19. Here, we observed a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:bioRxiv
Glavni autori: Fischer, Robert J., van Doremalen, Neeltje, Adney, Danielle R., Yinda, Claude Kwe, Port, Julia R., Holbrook, Myndi G., Schulz, Jonathan E., Williamson, Brandi N., Thomas, Tina, Barbian, Kent, Anzick, Sarah L., Ricklefs, Stacy, Smith, Brian J., Long, Dan, Martens, Craig, Saturday, Greg, de Wit, Emmie, Gilbert, Sarah C., Lambe, Teresa, Munster, Vincent J.
Format: Artigo
Jezik:Inglês
Izdano: Cold Spring Harbor Laboratory 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7987006/
https://ncbi.nlm.nih.gov/pubmed/33758847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2021.03.11.435000
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items